Literature DB >> 15820489

Identification of ethylsuccinylcarnitine present in some human urines.

Raymond Libert1, François Van Hoof, Georges Laus, Philippe De Nayer, Jean-Louis Habib Jiwan, Edmond de Hoffmann, André Schanck.   

Abstract

Ethylsuccinylcarnitine, a previously undescribed acylcarnitine, was identified in urines obtained from 81% of adult volunteers. Its chemical structure was obtained by 1H nuclear magnetic resonance spectroscopy of the urinary purified compound and confirmed by its chemical synthesis. Its urinary excretion followed a circadian rhythm with a maximum occurring between 8 p.m. and 1 a.m. Excretion of this compound was enhanced after a load of L-carnitine and in this case, total 24-h urinary excretion may raise up to about 75 microM. It was observed that the day after adryamicine treatment, the compound was no more excreted. This molecule was absent or in trace amounts in urines obtained from few adults as well as in urines obtained from young subjects. In the positive urines, we detected an unknown organic acid whose excretion was almost parallel to that of ethylsuccinylcarnitine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820489     DOI: 10.1016/j.cccn.2004.12.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Authors:  Jie Zhang; Alan R Light; Charles L Hoppel; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Ronald W Hughen; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Mary-Ellen Harper; Oliver Fiehn; Sean H Adams
Journal:  Exp Physiol       Date:  2016-12-12       Impact factor: 2.969

2.  Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.

Authors:  Zhi-Xiang Yan; Xue-Jiao Gao; Ting Li; Bin Wei; Pan-Pan Wang; Ying Yang; Ru Yan
Journal:  Appl Environ Microbiol       Date:  2018-07-02       Impact factor: 4.792

3.  Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.

Authors:  Jian-Jun Liu; Sujoy Ghosh; Jean-Paul Kovalik; Jianhong Ching; Hyung Won Choi; Subramaniam Tavintharan; Choon Nam Ong; Chee Fang Sum; Scott A Summers; E Shyong Tai; Su Chi Lim
Journal:  Kidney Int Rep       Date:  2016-12-16

4.  Metabolomic Quantitative Trait Loci (mQTL) Mapping Implicates the Ubiquitin Proteasome System in Cardiovascular Disease Pathogenesis.

Authors:  William E Kraus; Deborah M Muoio; Robert Stevens; Damian Craig; James R Bain; Elizabeth Grass; Carol Haynes; Lydia Kwee; Xuejun Qin; Dorothy H Slentz; Deidre Krupp; Michael Muehlbauer; Elizabeth R Hauser; Simon G Gregory; Christopher B Newgard; Svati H Shah
Journal:  PLoS Genet       Date:  2015-11-05       Impact factor: 5.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.